Biojector 2000 Open-Label Safety Study (BOSS) to Evaluate Signs and Symptoms Associated With a Needle-free Injection Device for Administration of Fuzeon to Patients With HIV-1 Infection
Phase of Trial: Phase IV
Latest Information Update: 07 Oct 2016
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms BOSS
- Sponsors Roche
- 18 Jan 2007 Status changed from recruiting to completed.
- 12 Jul 2006 New trial record.